-
-
Roche’s satralizumab significantly reduced relapse risk in second positive phase III study for neuromyelitis optica spectrum
-
13th Sep 2019
-
Posted in Industry News
- News from Roche at #ECTRIMS19
-
-
New Real-World Data Support Long-Term Efficacy and Safety Profile of MAVENCLAD®
-
13th Sep 2019
-
Posted in Industry News
- News of Mavenclad from #ECTRIMS19
-
-
Imcyse to present positive results in EAE model of multiple sclerosis at ECTRIMS 2019
-
12th Sep 2019
-
Posted in Industry News
- News from #ECTRIMS19
-
-
Improved NHS care for Parkinson’s, Multiple Sclerosis and Motor Neurone Disease to save 2,500 hospital trips
-
10th Sep 2019
-
Posted in News Review
- New online toolkit from the NHS
-
-
PathMaker Neurosystems – Publication of First Clinical Trial Results for MyoRegulator® Device for Non-Invasive Treatment of Spasticity
-
19th Aug 2019
-
Posted in Industry News
- News from PathMaker Neurosystems Inc.
-
-
Is transient global amnesia a form of non-convulsive status epilepticus?
-
2nd Aug 2019
-
Posted in Clinical Review Article
- Daniel Eschle
-
-
Can we repair the brain in Parkinson’s disease?
-
2nd Aug 2019
-
Posted in Clinical Review Article
- Roger Barker
-
-
From the editor…
-
2nd Aug 2019
-
Posted in Editor's introduction
- Mike Zandi
-
-
Pharmacological management of long-term aggression secondary to traumatic brain injuries
-
2nd Aug 2019
-
Posted in Clinical Review Article
- Anum Bhatti and George El-Nimr
-
-
Neurological literature: a clinical trial
-
2nd Aug 2019
-
Posted in Neurological Literature,Special Feature
- AJ Larner, Cognitive Function Clinic, Walton Centre for Neurology and Neurosurgery, Liverpool, L9 7LJ, UK. Correspondence to: Email: a.larner@thewaltoncentre.nhs.uk To cite: Larner AJ. ACNR...